cardiac glycosides	are	drugs
cardiac glycosides	treat	heart failure
cardiac glycosides	treat	atrial fibrillation
cardiac glycosides	increase	cardiac contractility
cardiac glycosides	decrease	heart rate
cardiac glycosides	inhibit	Na⁺/K⁺‑ATPase
Na⁺/K⁺‑ATPase	regulates	intracellular Na⁺
intracellular Na⁺	affects	Ca²⁺ influx
Ca²⁺ influx	enhances	myocardial force
cardiac glycosides	cause	arrhythmias
arrhythmias	lead to	sudden cardiac death
cardiac glycosides	have	narrow therapeutic index
narrow therapeutic index	requires	therapeutic drug monitoring
therapeutic drug monitoring	measures	serum digoxin
serum digoxin	correlates with	toxicity risk
cardiac glycosides	include	digoxin
cardiac glycosides	include	digitoxin
cardiac glycosides	include	ouabain
digoxin	metabolized by	liver
digoxin	excreted by	kidneys
digoxin	interacts with	amiodarone
digoxin	interacts with	verapamil
digoxin	interacts with	quinidine
digoxin	interacts with	cimetidine
digoxin	interacts with	proton pump inhibitors
digoxin	contraindicated in	renal failure
digoxin	contraindicated in	hyperkalemia
digoxin	contraindicated in	hypokalemia
digoxin	contraindicated in	bradycardia
digoxin	contraindicated in	atrioventricular block
digoxin	contraindicated in	ventricular ectopy
digitoxin	has	longer half‑life
digitoxin	used in	chronic heart failure
digitoxin	less	renal clearance
ouabain	used in	research models
ouabain	not	approved for clinical use
cardiac glycosides	cause	nausea
cardiac glycosides	cause	vomiting
cardiac glycosides	cause	visual disturbances
visual disturbances	include	blurred vision
visual disturbances	include	yellow‑green halos
cardiac glycosides	cause	dizziness
cardiac glycosides	cause	fatigue
cardiac glycosides	cause	anorexia
cardiac glycosides	cause	constipation
cardiac glycosides	cause	hypotension
cardiac glycosides	cause	tachycardia
cardiac glycosides	cause	palpitations
cardiac glycosides	cause	syncope
cardiac glycosides	cause	confusion
cardiac glycosides	cause	delirium
cardiac glycosides	cause	seizures
cardiac glycosides	cause	coma
cardiac glycosides	cause	death
cardiac glycosides	used as	positive inotropes
positive inotropes	improve	ejection fraction
ejection fraction	predicts	mortality
cardiac glycosides	improve	exercise tolerance
exercise tolerance	predicts	quality of life
cardiac glycosides	reduce	hospital readmission
hospital readmission	predicts	healthcare cost
cardiac glycosides	reduce	mortality
mortality	predicts	survival
cardiac glycosides	used in	guideline‑based therapy
guideline‑based therapy	includes	ACE inhibitors
guideline‑based therapy	includes	beta‑blockers
guideline‑based therapy	includes	diuretics
cardiac glycosides	used in	advanced heart failure
advanced heart failure	predicts	transplant need
cardiac glycosides	used in	refractory arrhythmias
refractory arrhythmias	predict	ICD implantation
ICD implantation	reduces	sudden death
cardiac glycosides	used in	ventricular tachycardia
ventricular tachycardia	predicts	arrhythmic death
cardiac glycosides	used in	atrial flutter
atrial flutter	predicts	stroke risk
stroke risk	predicts	anticoagulation
cardiac glycosides	used in	atrial fibrillation
atrial fibrillation	predicts	heart failure progression
heart failure progression	predicts	mortality
cardiac glycosides	used in	chronic kidney disease
chronic kidney disease	predicts	drug clearance
drug clearance	predicts	toxicity
cardiac glycosides	used in	elderly patients
elderly patients	predict	fall risk
fall risk	predicts	hospitalization
cardiac glycosides	used in	patients with electrolyte imbalance
electrolyte imbalance	predicts	arrhythmia risk
arrhythmia risk	predicts	mortality
cardiac glycosides	used in	patients with liver disease
liver disease	predicts	drug metabolism
drug metabolism	predicts	toxicity
cardiac glycosides	used in	patients with diabetes
diabetes	predicts	renal function
renal function	predicts	drug clearance
cardiac glycosides	used in	patients with hypertension
hypertension	predicts	cardiovascular risk
cardiovascular risk	predicts	mortality
cardiac glycosides	used in	patients with anemia
anemia	predicts	exercise capacity
